ES245396U - Dispositivo de inhalacion perfeccionado - Google Patents

Dispositivo de inhalacion perfeccionado

Info

Publication number
ES245396U
ES245396U ES1979245396U ES245396U ES245396U ES 245396 U ES245396 U ES 245396U ES 1979245396 U ES1979245396 U ES 1979245396U ES 245396 U ES245396 U ES 245396U ES 245396 U ES245396 U ES 245396U
Authority
ES
Spain
Prior art keywords
medicament
passageway
housing
holding container
emptying chamber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES1979245396U
Other languages
English (en)
Other versions
ES245396Y (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex Puerto Rico Inc
Original Assignee
Syntex Puerto Rico Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Puerto Rico Inc filed Critical Syntex Puerto Rico Inc
Publication of ES245396U publication Critical patent/ES245396U/es
Application granted granted Critical
Publication of ES245396Y publication Critical patent/ES245396Y/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nozzles (AREA)

Abstract

Dispositivo de inhalación perfeccionado, formado por dos partes y accionado por la respiración para dispensar un medicamento en polvo desde un contenedor portador de medicamento en polvo, caracterizado porque la primera parte del dispositivo comprende un alojamiento alargado provisto de un paso para el movimiento del aire a través del mismo, un extremo de cuyo alojamiento es un extremo de salida apto para la introducción en la boca o conducto nasal del usuario, cuyo paso presenta un extremo de entrada que termina en una cámara de descarga situada en dicho extremo de salida de dicho alojamiento, siendo la sección del paso menor que la de la cámara de descarga, comprendiendo dicha primera parte medios receptores de la segunda para del dispositivo y la segunda parte comprende medios receptores del contenedor portador de medicamento y aptos para su recepción en forma deslizante por dichos medios receptores de dicha primera parte de manera que cuando se coloca un contenedor portador de medicamento en dichos medios receptores de contenedor de dicha segunda parte y las dos partes se mueven una con relación a otra, el extremo abierto del contenedor portador de medicamento se posiciona adyacente al extremo interno de la cámara de descarga, con lo que, durante la inhalación, una parte de aire que circula a través del paso fluye hacia el interior del contenedor portador de medicamento para dispensar el medicamento desde el contenedor.
ES1979245396U 1978-09-05 1979-09-04 Dispositivo de inhalacion perfeccionado Expired ES245396Y (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/939,615 US4227522A (en) 1978-09-05 1978-09-05 Inhalation device

Publications (2)

Publication Number Publication Date
ES245396U true ES245396U (es) 1979-12-16
ES245396Y ES245396Y (es) 1980-06-16

Family

ID=25473465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES1979245396U Expired ES245396Y (es) 1978-09-05 1979-09-04 Dispositivo de inhalacion perfeccionado

Country Status (8)

Country Link
US (1) US4227522A (es)
BE (1) BE878602A (es)
BR (1) BR5901188U (es)
DE (1) DE7924611U1 (es)
ES (1) ES245396Y (es)
FR (1) FR2435254A1 (es)
IT (1) IT7953541V0 (es)
ZA (1) ZA794696B (es)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
GB9216038D0 (en) * 1992-07-28 1992-09-09 Bespak Plc Dispensing apparatus for powdered medicaments
WO1994020164A1 (en) * 1993-03-03 1994-09-15 Glaxo Wellcome Inc. Dry powder inhalator medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
US5505194A (en) * 1994-03-23 1996-04-09 Abbott Laboratories Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
FR2731911B1 (fr) * 1995-03-20 1997-08-14 Paul Seyvos Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
DE59605366D1 (de) 1995-12-07 2000-07-06 Jago Pharma Ag Muttenz Inhalator zur mehrfachen dosisweisen abgabe eines pharmakologischen trockenpulvers
US7131441B1 (en) 1995-12-07 2006-11-07 Skyepharma Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US20030203036A1 (en) 2000-03-17 2003-10-30 Gordon Marc S. Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
CA2212430A1 (en) * 1997-08-07 1999-02-07 George Volgyesi Inhalation device
UA73924C2 (en) * 1998-10-09 2005-10-17 Nektar Therapeutics Device for delivering active agent formulation to lungs of human patient
DE29908593U1 (de) 1999-05-14 1999-07-22 Jago Research AG, Hergiswil Mundstück für einen Inhalator zur Abgabe eines Medikaments
US7089934B2 (en) 2000-02-28 2006-08-15 Vectura Limited Delivery of oral drugs
US6595210B2 (en) * 2000-11-27 2003-07-22 Unisia Jecs Corporation Inhalator for administering powder composition
GB2380410B (en) * 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
WO2003078448A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
ITMO20020297A1 (it) * 2002-10-16 2004-04-17 Roberto Oliva Inalatore per preparati monodose in capsule.
US20060045849A1 (en) * 2004-08-24 2006-03-02 Farhan Taghizadeh Method of customizing the fragrance of nasal medications
PL370285A1 (pl) * 2004-09-23 2006-04-03 Glaxosmithkline Pharmaceuticals Spółka Akcyjna Inhalator proszkowy
US8221804B2 (en) 2005-02-03 2012-07-17 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US8653028B2 (en) 2005-04-29 2014-02-18 Rui Rong Yuan Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
US9585932B2 (en) 2005-04-29 2017-03-07 Peter C. Dowling Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
US9345745B2 (en) * 2005-04-29 2016-05-24 Bo Wang Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
US20090192227A1 (en) * 2005-08-24 2009-07-30 Rabindra Tirouvanziam N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
WO2007024876A2 (en) * 2005-08-24 2007-03-01 The Board Of Trustees Of Leland Stanford Junior University Methods for treating and monitoring inflammation and redox imbalance in cystic fibrosis
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
GB0604444D0 (en) * 2006-03-06 2006-04-12 Optinose As Nasal devices
AU315527S (en) 2006-09-28 2007-08-03 Glaxo Group Ltd Inhalation device
EP2606903B1 (en) * 2007-01-10 2016-09-14 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and uses therefor
ES2547229T3 (es) 2007-08-07 2015-10-02 Purdue Research Foundation Inhibidores de cinasa y usos de los mismos
AU2009212166A1 (en) 2008-02-07 2009-08-13 University Of Washington Circumferential aerosol device
WO2009143380A2 (en) * 2008-05-21 2009-11-26 Neurotez, Inc. Methods for treating progressive cognitive disorders related to neurofibrillary tangles
TWI677355B (zh) * 2008-06-13 2019-11-21 美商曼凱公司 用於藥物傳輸之乾粉吸入器及系統
CN102256613B (zh) * 2008-10-20 2014-09-10 莫伊莱麦屈克斯公司 用于治疗或者预防粘连的多肽
AU2009313562B2 (en) * 2008-11-04 2012-11-15 Neurotez, Inc. Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
CN102316731B (zh) * 2008-12-10 2016-06-01 普渡研究基金会 基于细胞渗透性肽的激酶抑制剂
MY159856A (en) 2009-07-24 2017-02-15 Amazentis Sa Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
US9890195B2 (en) * 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
CA2828884C (en) 2011-03-03 2021-04-27 Impel Neuropharma, Inc. Nasal drug delivery device
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
JP6031510B2 (ja) 2011-04-12 2016-11-24 モイライ マトリックス インコーポレイテッド 異常な線維芽細胞増殖及び細胞外マトリックスの沈着を特徴とする疾患、症状又はプロセスを予防又は治療する組成物及び方法
US9579337B2 (en) 2011-04-25 2017-02-28 Cornell University Use of uridine and deoxyuridine to treat folate-responsive pathologies
WO2012154859A1 (en) 2011-05-09 2012-11-15 Impel Neuropharma Inc. Nozzles for nasal drug delivery
EP2589381B1 (en) 2011-11-04 2016-08-31 Rabindra Tirouvanziam Compositions for improving or preserving lung function in a patient with a pulmonary disorder
US9452218B2 (en) 2012-03-09 2016-09-27 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2014039533A2 (en) 2012-09-04 2014-03-13 Eleison Pharmaceuticals, Llc Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
US10537692B2 (en) 2013-04-28 2020-01-21 Impel Neuropharma, Inc. Medical unit dose container
US10207065B2 (en) 2013-07-12 2019-02-19 John H. Silva Mouthpiece for inhalers
EP3044218B1 (en) 2013-09-10 2020-05-27 Board Of Regents Of the University Of Texas System Therapeutics targeting truncated adenomatous polyposis coli (apc) proteins
US10336788B2 (en) 2014-04-17 2019-07-02 Moerae Matrix, Inc. Inhibition of cardiac fibrosis in myocardial infarction
USD748242S1 (en) 2014-07-11 2016-01-26 H. Stuart Campbell Inhaler mouthpiece
US10082496B2 (en) 2014-09-10 2018-09-25 Board Of Regents Of The University Of Texas System Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
KR20170083063A (ko) 2014-11-17 2017-07-17 모레 매트릭스 인코포레이티드 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정의 예방 또는 치료용 조성물 및 방법
JP6921755B2 (ja) 2014-12-10 2021-08-18 ハイパーステム ソシエテ アノニム 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物
MX2017008994A (es) 2015-01-08 2018-09-18 Moerae Matrix Inc Formulacion de peptidos inhibidores mk2.
RU2017135072A (ru) 2015-03-12 2019-04-10 Мори Матрикс, Инк. Применение пептидсодержащих композиций ингибитора mk2 для лечения немелкоклеточного рака легкого
WO2016200694A1 (en) 2015-06-10 2016-12-15 Hackensack University Medical Center Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
WO2017007634A1 (en) 2015-07-06 2017-01-12 The Board Of Regents Of The University Of Texas System Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
EP3322417B1 (en) 2015-07-15 2023-08-23 The Board of Regents of The University of Texas System Targeting emopamil binding protein (ebp) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
AU2016321345B2 (en) 2015-09-10 2020-12-10 Impel Pharmaceuticals Inc. In-line nasal delivery device
US11833118B2 (en) 2016-01-20 2023-12-05 Flurry Powders, Llc Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
WO2017127641A1 (en) 2016-01-20 2017-07-27 Flurry Powders Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
EP3713628A4 (en) 2017-11-21 2021-08-18 Impel Neuropharma Inc. INTRA-NASAL DEVICE WITH DIVER TUBE
US11395887B2 (en) 2017-11-21 2022-07-26 Impel Pharmaceuticals Inc. Intranasal device with inlet interface
EP3735244B1 (en) 2018-01-05 2022-11-23 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
CA3087698A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of olanzapine by precision olfactory device
CN112955134A (zh) 2018-07-19 2021-06-11 英倍尔药业股份有限公司 用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
NZ777687A (en) 2019-01-03 2023-12-22 Impel Pharmaceuticals Inc Nasal drug delivery device
AU2020277313A1 (en) 2019-05-17 2022-01-20 Impel Pharmaceuticals Inc. Single-use nasal delivery device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2587215A (en) * 1949-04-27 1952-02-26 Frank P Priestly Inhalator
IT1017153B (it) * 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments

Also Published As

Publication number Publication date
FR2435254A1 (fr) 1980-04-04
DE7924611U1 (de) 1979-11-29
BR5901188U (pt) 1980-06-17
US4227522A (en) 1980-10-14
ZA794696B (en) 1981-04-29
ES245396Y (es) 1980-06-16
IT7953541V0 (it) 1979-08-29
BE878602A (fr) 1980-03-05

Similar Documents

Publication Publication Date Title
ES245396U (es) Dispositivo de inhalacion perfeccionado
ES245395U (es) Dispositivo de inhalacion con abridor de capsula
ES448763A1 (es) Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento.
ES444239A1 (es) Un dispositivo para inhalacion destinado a administrar un medicamento desde un recipiente que lo contiene.
GB1526303A (en) Device for the inhalation of medicaments
GB1520064A (en) Inhalation device
ATE144155T1 (de) Abgabevorrichtung für pulverförmige arzneistoffe
AU550712B2 (en) Aerosol can medicament oral inhalator
GB9626233D0 (en) Medicament packaging and deliveery device
GR1002387B (el) Συσκευη εισπνοων.
MY105368A (en) Inhalation device.
GR3022762T3 (en) Inhalation devices
EP0965355A3 (de) Gesteuerter Inhalator
MY132275A (en) Nasal applicator
MY112427A (en) Medicament inhaler and method
EP0640354A3 (en) Inhaler for swirl powders.
ES466771A1 (es) Perfeccionamientos en dispositivos para aspiradores traquea-les
IE42623L (en) Inhalatin device
GB9706121D0 (en) Inhalation device
ES444238A1 (es) Un dispositivo de inhalacion.
GB8914223D0 (en) Medicament container
DE3166033D1 (en) Apparatus for inhalation
ES8400245A1 (es) Dispositivo de inhalacion para medicamento en un recipiente aerosol.
MX9701196A (es) Aparato inhalador con camara de optimizacion.

Legal Events

Date Code Title Description
FD1K Utility model lapsed

Effective date: 19980601